Sin conexión a internet: se muestra la versión guardada de la página.

IQVIA Holdings In…

USUSD
← Al Screener

IQVIA Holdings Inc (LSE:0JDM) — Biotechnology: Commercial Physical & Biological Resarch. Número de bolsas en las que cotizan las acciones de la empresa: 2. En esta página: cotización y gráfico, dividendos, principales accionistas e historial del número de acciones.

Sobre la Empresa

Sitio Web
iqvia.com
Relaciones con los Inversores
ir.iqvia.com/
Sector
Health Care · Biotechnology: Commercial Physical & Biological Resarch
Sede Central
Durham, United States
Consejero Delegado
Ari Bousbib
Empleados
94 000
Fundada
2016
Cotiza Desde
29.01.2018 (LSE:0JDM)
Acciones en Circulación
164.6 M a 2026-07-21
Capital Flotante
156.25 M
Capitalización Bursátil
44.25 mil M USD
Insiders
1.09%
Inversores Institucionales
103.42%
Industria (SIC)
Services-Commercial Physical & Biological Research
ISIN
US46266C1053
LEI
549300W3R20NM4KQPH86
P/E
47.1
Ratio de Reparto
41.0%
FCF
2.12 mil M USD
Pagos / FCF
27%
Deuda
15.8 mil M USD
6.6 a. de FCF
Racha de Dividendos
—
Beneficios, FCF y dividendos pagados — para los 12 meses hasta 31.03.2026 (el último informe de la compañía).
NAV
37.27 USD · P/NAV 7.00
Fecha del Balance31.03.2026
Activos29.7 mil M USD
− Pasivos23.3 mil M USD
= Patrimonio Total6.35 mil M USD
− Participaciones No Dominantes128 M USD
= NAV (patrimonio de los accionistas de la empresa)6.22 mil M USD
− Fondo de Comercio16.5 mil M USD
− Activos Intangibles4.80 mil M USD
= NAV Tangible−15.1 mil M USD
Acciones166 900 000
NAV por Acción37.27 USD
NAV Tangible por Acción−90.63 USD
Precio de la Acción (0JDM)261.01 USD
P/NAV7.00
Historial del NAV
Fecha del BalanceNAVNAV por Acción
31.03.20266.22 mil M USD37.27 USD
31.12.20256.50 mil M USD38.34 USD
30.09.20256.16 mil M USD36.17 USD
30.06.20255.78 mil M USD33.99 USD
31.03.20255.98 mil M USD34.33 USD
31.12.20246.07 mil M USD34.45 USD
30.09.20246.97 mil M USD38.36 USD
30.06.20246.71 mil M USD36.83 USD
Descripción

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and associated implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with Kexing Biopharm Co., Ltd. for biosimilar development. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. is based in Durham, North Carolina.

anuncio

Bolsas y Tickers

BolsaTickerMonedaPrecioTipo
US USA StocksIQV principalUSD271.04 +3.45%acciones ordinarias
LSE London Stock Exchange0JDM IOBUSD261.01 +0.00%acciones ordinarias

Precio en 3 Meses

día alcista día bajista fecha ex-dividendo fecha de pagoPasa el cursor / toca un día — precios de apertura, cierre, máximo y mínimo

Dividendos

No se han encontrado pagos de dividendos (comprobado el 17.10.2026). Es probable que la empresa no reparta dividendos.

Noticias de Esta Semana

Comunicados de prensa desde la página web para inversores de la empresa, actualizados diariamente. Los enlaces conducen a la página web de la empresa. Los titulares están en el idioma original, como en la página web de la empresa.

Principales Accionistas

TitularParticipaciónAccionesFecha del Informe
Blackrock Inc.8.84%14.55 M2026-06-30
Harris Associates L.P.7.4%12.18 M2026-06-30
Vanguard Capital Managem…6.63%10.91 M2026-06-30
State Street Corporation4.56%7.51 M2026-06-30
Vanguard Portfolio Manag…4.56%7.5 M2026-06-30
JPMORGAN CHASE & CO3.73%6.14 M2026-06-30
VANGUARD INDEX FUNDS-Van…3.22%5.3 M2026-06-30
Artisan Partners Limited…2.88%4.74 M2026-06-30
Boston Partners2.71%4.47 M2026-06-30
Geode Capital Management…2.71%4.45 M2026-06-30
VANGUARD INDEX FUNDS-Van…2.63%4.32 M2026-06-30
VANGUARD INDEX FUNDS-Van…2.2%3.62 M2026-06-30
Invesco Ltd.1.99%3.28 M2026-06-30
HARRIS ASSOCIATES INVEST…1.58%2.61 M2026-06-30
HARRIS ASSOCIATES INVEST…1.56%2.57 M2026-06-30
iShares Trust-iShares Co…1.35%2.22 M2026-08-31
Fidelity Concord Street…1.31%2.16 M2026-07-31
SPDR S&P 500 ETF TRUST-S…1.24%2.04 M2026-08-31
VANGUARD WINDSOR FUNDS-V…1.07%1.76 M2026-07-31
VANGUARD INDEX FUNDS-Van…0.96%1.59 M2026-06-30
BOUSBIB ARI B (Chief Exe…≈0.84%1.38 M2026-07-29
BRUEHLMAN RONALD E (Chie…≈0.03%55 9962026-02-06
HAAS BERND (Officer)≈0.01%24 4142026-02-06
GRENFELL ALISTAIR (Offic…≈0.01%24 1242026-02-06
SHERBET ERIC M (General…≈0.01%20 9992026-07-29
LEONARD JOHN M (Director…≈0.01%16 9462026-04-23
GOGGINS COLLEEN A (Direc…≈0.01%14 4532026-04-23
STAUB WALTER. RICHARD II…≈0.01%13 3122026-08-03
FEDOCK MICHAEL J. (Offic…≈0.01%9 5952026-02-06
DANHAKL JOHN G (Director…——2026-04-23